*	OR T1 T2
R1	Has_value Arg1:T3 Arg2:T4	
R2	Has_value Arg1:T5 Arg2:T8	
R3	Has_qualifier Arg1:T9 Arg2:T16	
*	OR T18 T19 T20 T21
R4	Has_qualifier Arg1:T18 Arg2:T22	
R5	AND Arg1:T24 Arg2:T25	
R6	Has_temporal Arg1:T25 Arg2:T26	
R7	Has_value Arg1:T27 Arg2:T28	
R8	multi Arg1:T29 Arg2:T30	
R9	Has_qualifier Arg1:T27 Arg2:T29	
R10	Has_qualifier Arg1:T10 Arg2:T16	
R11	Has_qualifier Arg1:T11 Arg2:T16	
R12	Has_qualifier Arg1:T12 Arg2:T16	
R13	Has_qualifier Arg1:T13 Arg2:T16	
R14	Has_qualifier Arg1:T6 Arg2:T16	
R15	Has_qualifier Arg1:T7 Arg2:T16	
R16	Has_qualifier Arg1:T14 Arg2:T16	
R17	Has_qualifier Arg1:T15 Arg2:T16	
T1	Condition 79 102	high risk blood disease
T2	Condition 106 112	cancer
T3	Measurement 140 165	Estimated life expectancy
T4	Value 169 207	at least 6 weeks following study entry
T5	Measurement 209 263	Cancer and Leukemia Group B (CALGB) performance status
T8	Value 264 287	less than or equal to 2
T9	Measurement 289 311	White blood cell count
T10	Measurement 313 321	platelet
T11	Measurement 323 333	hematocrit
T12	Measurement 335 347	tuberculosis
T13	Measurement 349 381	aspartate aminotransferase (AST)
T6	Measurement 383 413	alanine aminotransferase (ALT)
T7	Measurement 415 435	alkaline phosphatase
T14	Measurement 437 447	creatinine
T15	Measurement 453 469	HIV test results
T16	Qualifier 470 499	reviewed by transplant center
T18	Procedure 501 534	Multiple gated acquisition (MUGA)
T19	Procedure 536 550	echocardiogram
T20	Procedure 552 563	cardiac MRI
T21	Procedure 572 602	pulmonary function tests (PFT)
T22	Qualifier 617 646	reviewed by transplant center
T24	Person 970 976	female
T25	Procedure 993 1006	contraception
T26	Temporal 1007 1027	throughout the study
T27	Measurement 909 945	umbilical cord blood units available
T28	Value 888 905	Sufficient number
T29	Qualifier 946 965	for transplantation
T30	Procedure 950 965	transplantation
